Progressive Multifocal Leukoencephalopathy and Natalizumab — Unforeseen Consequences Progressive Multifocal Leukoencephalopathy and Natalizumab — Unforeseen Consequences2018-01-17T17:02:55-05:00
Cost of Managing an Episode of Relapse in Multiple Sclerosis in the United States Cost of Managing an Episode of Relapse in Multiple Sclerosis in the United States2018-01-17T17:02:55-05:00
Marijuana as a treatment for epilepsy and multiple sclerosis? Marijuana as a treatment for epilepsy and multiple sclerosis?2018-01-17T17:02:49-05:00
Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis2018-01-17T17:02:43-05:00
Daclizumab Zenapax inhibits early interleukin-2 receptor / signal transduction events Daclizumab Zenapax inhibits early interleukin-2 receptor / signal transduction events2018-01-17T17:02:37-05:00
Sequential maintenance treatment with glatiramer acetate after mitoxantrone is safe and can limit exposure to immunosuppression in very active, relapsing remitting multiple sclerosis Sequential maintenance treatment with glatiramer acetate after mitoxantrone is safe and can limit exposure to immunosuppression in very active, relapsing remitting multiple sclerosis2018-01-17T17:02:30-05:00
Copaxone’s effect on MRI-monitored disease in relapsing MS is reproducible and sustained Copaxone’s effect on MRI-monitored disease in relapsing MS is reproducible and sustained2018-01-17T17:02:24-05:00
Modafinil Is Safe and Effective Treatment for MS-Related Fatigue Modafinil Is Safe and Effective Treatment for MS-Related Fatigue2018-01-17T17:02:18-05:00
Liver injury associated with the B-interferons for MS Liver injury associated with the B-interferons for MS2018-01-17T17:02:05-05:00
